565 related articles for article (PubMed ID: 25652642)
1. Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Srinivasan M; Lahiri DK
Expert Opin Ther Targets; 2015 Apr; 19(4):471-87. PubMed ID: 25652642
[TBL] [Abstract][Full Text] [Related]
2. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.
Seo EJ; Fischer N; Efferth T
Pharmacol Res; 2018 Mar; 129():262-273. PubMed ID: 29179999
[TBL] [Abstract][Full Text] [Related]
3. Genistein antagonizes inflammatory damage induced by β-amyloid peptide in microglia through TLR4 and NF-κB.
Zhou X; Yuan L; Zhao X; Hou C; Ma W; Yu H; Xiao R
Nutrition; 2014 Jan; 30(1):90-5. PubMed ID: 24290604
[TBL] [Abstract][Full Text] [Related]
4. The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease.
Sun E; Motolani A; Campos L; Lu T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012242
[TBL] [Abstract][Full Text] [Related]
5. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Abeta production by NF-kappaB inhibitors.
Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
[TBL] [Abstract][Full Text] [Related]
7. UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS.
Verma Y; Sachdeva H; Kalra S; Kumar P; Singh G
Georgian Med News; 2023 Sep; (342):133-141. PubMed ID: 37991969
[TBL] [Abstract][Full Text] [Related]
8. NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.
Ju Hwang C; Choi DY; Park MH; Hong JT
CNS Neurol Disord Drug Targets; 2019; 18(1):3-10. PubMed ID: 28782486
[TBL] [Abstract][Full Text] [Related]
9. Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease.
Shi ZM; Han YW; Han XH; Zhang K; Chang YN; Hu ZM; Qi HX; Ting C; Zhen Z; Hong W
J Neurol Sci; 2016 Jul; 366():127-134. PubMed ID: 27288790
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.
Collister KA; Albensi BC
Drug News Perspect; 2005 Dec; 18(10):623-9. PubMed ID: 16491164
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection.
Kaur U; Banerjee P; Bir A; Sinha M; Biswas A; Chakrabarti S
Curr Top Med Chem; 2015; 15(5):446-57. PubMed ID: 25620241
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of NF-kappaB signaling: 785 and counting.
Gilmore TD; Herscovitch M
Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) - a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease.
Marwarha G; Ghribi O
CNS Neurol Disord Drug Targets; 2017; 16(10):1050-1065. PubMed ID: 28745240
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappa B inhibitors; a patent review (2006-2010).
Kwak JH; Jung JK; Lee H
Expert Opin Ther Pat; 2011 Dec; 21(12):1897-910. PubMed ID: 22098320
[TBL] [Abstract][Full Text] [Related]
15. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
[TBL] [Abstract][Full Text] [Related]
16. Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer's disease via SIRT1/NF-κB pathway.
Gao J; Zhou R; You X; Luo F; He H; Chang X; Zhu L; Ding X; Yan T
Metab Brain Dis; 2016 Aug; 31(4):771-8. PubMed ID: 26909502
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Mc Guire C; Prinz M; Beyaert R; van Loo G
Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
[TBL] [Abstract][Full Text] [Related]
18. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex.
Lukiw WJ; Bazan NG
J Neurosci Res; 1998 Sep; 53(5):583-92. PubMed ID: 9726429
[TBL] [Abstract][Full Text] [Related]
19. Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia.
Nijboer CH; Heijnen CJ; Groenendaal F; van Bel F; Kavelaars A
Stroke; 2009 Oct; 40(10):3362-8. PubMed ID: 19628795
[TBL] [Abstract][Full Text] [Related]
20. Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.
Qin ZH; Tao LY; Chen X
Acta Pharmacol Sin; 2007 Dec; 28(12):1859-72. PubMed ID: 18031598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
